Categories: News

Verantos Named to Inc. 5000 List for the Third Consecutive Year

Global leader in high-validity real-world evidence for life sciences grows more than 3x in three years

PALO ALTO, Calif., Aug. 16, 2024 /PRNewswire/ — Verantos, the global leader in high-validity real-world evidence (RWE) for the life sciences, marks its third consecutive appearance on the Inc. 5000, ranking No. 1393 on the annual list of the fastest-growing private companies in America. The prestigious Inc. 5000 provides a data-driven look at the most successful independent and entrepreneurial businesses in the U.S. Past honorees including Microsoft, Meta, Chobani, and Under Armour.

Verantos is the only RWE company to earn a spot on the Inc. 5000 list this year.

Verantos’ appearance on the Inc. 5000 underscores the rapid adoption of high-validity real-world evidence and Verantos’ commitment to providing life sciences organizations with rich and reliable real-world data (RWD) through advanced curation, linkage, and enrichment.

“Our sustained growth reflects the value we deliver to our clients, including by providing them with the rich and reliable real-world data they need to advance groundbreaking treatments,” said Dan Riskin, Verantos CEO. “We are honored to be recognized alongside many other dynamic and entrepreneurial companies for the third consecutive year.”

Inc. reports the Inc. 5000 class of 2024 represents companies that have driven rapid revenue growth while navigating inflationary pressure, the rising costs of capital, and seemingly intractable hiring challenges.

About Verantos
Verantos is the global leader in high-validity real-world evidence at scale. By applying artificial intelligence to the complete patient record, Verantos enables life sciences organizations to generate high-validity evidence across therapeutic areas with measured accuracy, completeness, and traceability. Credible evidence accelerates clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives. For more information, visit Verantos.com or follow us on LinkedIn.

Media Contact
Smriti Shakargaye for Verantos
prforverantos@bospar.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/verantos-named-to-inc-5000-list-for-the-third-consecutive-year-302223952.html

SOURCE Verantos

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

17 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

17 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago